Evexia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 25-12-2024
- Paid Up Capital ₹ 2.38 Cr
as on 25-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -35.76%
(FY 2021)
- Profit -9.38%
(FY 2021)
- Ebitda -9.22%
(FY 2021)
- Net Worth -45.22%
(FY 2021)
- Total Assets -16.80%
(FY 2021)
About Evexia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.38 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashim Desai and Sharmin Contractor serve as directors at the Company.
- CIN/LLPIN
U24233MH2015PTC269536
- Company No.
269536
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Evexia Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashim Desai  | Director | 23-Oct-2015 | Current |
| Sharmin Contractor | Director | 23-Oct-2015 | Current |
Financial Performance of Evexia Life Sciences.
Evexia Life Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 35.76% decrease. The company also saw a slight decrease in profitability, with a 9.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evexia Life Sciences?
In 2021, Evexia Life Sciences had a promoter holding of 69.97% and a public holding of 30.03%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lozet Pharma Private LimitedActive 4 years 3 months
Ashim Desai and Sharmin Contractor are mutual person
- Vina Ashit Desai Traders Financers Company Pvt LtdActive 41 years 8 months
Ashim Desai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Evexia Life Sciences?
Evexia Life Sciences has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evexia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evexia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
